ReviewCurrent atherosclerosis reports2025

The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention.

Chukwuemezie Kamanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.